Polaris Venture Partners Founders' Fund V, L.P.
CIK 1439588 · last filed 2019-07-17
Polaris Venture Partners Founders' Fund V, L.P. is a corporate insider who has filed 8 SEC Form 4 insider transactions across 4 companies since 2014. The most recent filing shows the insider sold $9.5M of CDLX on Jul 17, 2019. Across all open-market trades the lifetime net is −$21.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $17.5K across reported positions. The firm reports its address in Boston, MA. 57 SEC filings were submitted jointly with Polaris Venture Management Co. V, L.L.C.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$17.5K
4
8
-$21.52M
Filer Profile
10TH FLOOR
BOSTON, MA 02210
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CDLX | Director | 4,205 | $4.15 | $17.5K | -$28.29M | 3 | 2019-07-17 |
| T2 Biosystems, Inc. (TTOO) Delisted | 10%+ Owner | 408 | $0.00 | $1 | -$5.00M | 2 | 2015-07-24 |
| GENOCEA BIOSCIENCES, INC. (GNCA) Delisted | 10%+ Owner | 246,201 | $0.00 | $148 | $12.01M | 2 | 2015-06-19 |
| TREVENA INC (TRVN) Delisted | 10%+ Owner | 115 | $0.01 | $1 | -$244.2K | 1 | 2014-08-15 |
Recent Filings
8 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-07-17 | CDLX | Sell (S) | −343,635 | -$9.50M | EDGAR |
| 2018-09-14 | CDLX | Sell (S) | −750,000 | -$18.78M | EDGAR |
| 2018-08-09 | CDLX | Mixed | +331,820 | $133 | EDGAR |
| 2015-07-24 | T2 Biosystems, Inc. (TTOO) Delisted | Sell (S) | −76,995 | -$1.16M | EDGAR |
| 2015-06-26 | T2 Biosystems, Inc. (TTOO) Delisted | Sell (S) | −224,985 | -$3.84M | EDGAR |
| 2015-06-19 | GENOCEA BIOSCIENCES, INC. (GNCA) Delisted | Sell (S) | −150,020 | -$1.96M | EDGAR |
| 2014-08-15 | TREVENA INC (TRVN) Delisted | Sell (S) | −39,900 | -$244.2K | EDGAR |
| 2014-02-11 | GENOCEA BIOSCIENCES, INC. (GNCA) Delisted | Mixed | +10,643,390 | $13.97M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.